Literature DB >> 35606341

Short-term natural course of esophageal thermal injury after ablation for atrial fibrillation.

Yuki Ishidoya1,2, Eugene Kwan1,2,3, Derek J Dosdall1,2,3,4, Rob S Macleod2,3, Leenhapong Navaravong1,2, Benjamin A Steinberg1,2, T Jared Bunch1, Ravi Ranjan2,3.   

Abstract

INTRODUCTION: Esophageal injury is rare but potentially a devastating complication of atrial fibrillation (AF) ablation. The goal here was to provide insight into the short-term natural history of esophageal thermal injury (ETI) after radiofrequency catheter ablation (RFCA) for AFby esophagogastroduodenoscopy (EGD).
METHODS: We screened patients who underwent RFCA for AF and EGD based on esophageal late gadolinium enhancement (LGE) in postablation magnetic resonance imaging. Patients with ETI diagnosed with EGD were included. We defined severity of ETI according to Kansas City classification: type 1: erythema; type 2: ulcers (2a: superficial; 2b deep); type 3 perforation (3a: perforation; 3b: perforation with atrioesophageal fistula [AEF]). Repeated EGD was performed within 1-14 days after the last EGD if recommended and possible until any certain healing signs (visible reduction in size without deepening of ETI or complete resolution) were observed.
RESULTS: ETI was observed in 62 of 378 patients who underwent EGD after RFCA. Out of these 62 patients with ETI, 21% (13) were type 1, 50% (31) were type 2a and 29% (18) were type 2b at the initial EGD. All esophageal lesions, but one type 2b lesion that developed into an AEF, showed signs of healing in repeated EGD studies within 14 days after the procedure. The one type 2b lesion developing into an AEF showed an increase in size and ulcer deepening in repeat EGD 8 days after the procedure.
CONCLUSION: We found that all ETI which did not progress to AEF presented healing signs within 14 days after the procedure and that worsening ETI might be an early signal for developing esophageal perforation.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; esophageal thermal injury; esophagogastroduodenoscopy; radiofrequency

Mesh:

Substances:

Year:  2022        PMID: 35606341      PMCID: PMC9276649          DOI: 10.1111/jce.15553

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873            Impact factor:   2.942


  21 in total

1.  Catheter ablation of atrial fibrillation using ablation index-guided high power (50 W) for pulmonary vein isolation with or without esophageal temperature probe (the AI-HP ESO II).

Authors:  Shaojie Chen; Boris Schmidt; Alexander Seeger; Stefano Bordignon; Shota Tohoku; Franziska Willems; Lukas Urbanek; Christina Throm; Athanasios Konstantinou; Karin Plank; Max Hilbert; Simone Zanchi; Lorenzo Bianchini; Fabrizio Bologna; Nikolaos Tsianakas; Claudia Kreuzer; K R Julian Chun
Journal:  Heart Rhythm       Date:  2020-05-26       Impact factor: 6.343

2.  Global survey of esophageal and gastric injury in atrial fibrillation ablation: incidence, time to presentation, and outcomes.

Authors:  Chirag R Barbhaiya; Saurabh Kumar; Roy M John; Usha B Tedrow; Bruce A Koplan; Laurence M Epstein; William G Stevenson; Gregory F Michaud
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

3.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Hugh Calkins; Lin Y Chen; Joaquin E Cigarroa; Joseph C Cleveland; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Karen L Furie; Paul A Heidenreich; Katherine T Murray; Julie B Shea; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2019-01-28       Impact factor: 24.094

Review 4.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

5.  High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization.

Authors:  Eran Leshem; Israel Zilberman; Cory M Tschabrunn; Michael Barkagan; Fernando M Contreras-Valdes; Assaf Govari; Elad Anter
Journal:  JACC Clin Electrophysiol       Date:  2018-02-02

6.  Severity of esophageal injury predicts time to healing after radiofrequency catheter ablation for atrial fibrillation.

Authors:  Fernando M Contreras-Valdes; E Kevin Heist; Stephan B Danik; Conor D Barrett; Dan Blendea; William R Brugge; Leon Ptaszek; Jeremy N Ruskin; Moussa Mansour
Journal:  Heart Rhythm       Date:  2011-07-23       Impact factor: 6.343

7.  Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study.

Authors:  Guido A Rosito; Joseph M Massaro; Udo Hoffmann; Frederick L Ruberg; Amir A Mahabadi; Ramachandran S Vasan; Christopher J O'Donnell; Caroline S Fox
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

8.  High-power short duration and low-power long duration in atrial fibrillation ablation: A meta-analysis.

Authors:  Jakrin Kewcharoen; Chol Techorueangwiwat; Chanavuth Kanitsoraphan; Thiratest Leesutipornchai; Nazem Akoum; Thomas J Bunch; Leenhapong Navaravong
Journal:  J Cardiovasc Electrophysiol       Date:  2020-11-18

9.  Gastric and duodenal ulcer healing under placebo treatment.

Authors:  U Scheurer; L Witzel; F Halter; H M Keller; R Huber; R Galeazzi
Journal:  Gastroenterology       Date:  1977-05       Impact factor: 22.682

10.  Five seconds of 50-60 W radio frequency atrial ablations were transmural and safe: an in vitro mechanistic assessment and force-controlled in vivo validation.

Authors:  Abhishek Bhaskaran; William Chik; Jim Pouliopoulos; Chrishan Nalliah; Pierre Qian; Tony Barry; Fazlur Nadri; Rahul Samanta; Ying Tran; Stuart Thomas; Pramesh Kovoor; Aravinda Thiagalingam
Journal:  Europace       Date:  2017-05-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.